SCANDINAVIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150 MG DESOGESTREL AND 0.030 MG ETHINYLESTRADIOL

被引：0
|
作者：
BORGLIN, NE
CHRISTENSEN, OJE
CULLBERG, G
ENGER, L
FJAERESTAD, I
KLOTTRUP, P
ODLIND, V
SANDAGER, T
SECHER, K
ASSENDORP, R
机构：
[1] GYNECOL PRACTICE,MALMO,SWEDEN
[2] OSTFOLD,DEPT GYNECOL SENTRALSYKEHUSET,FREDERIKSTAD,NORWAY
[3] LASARETTET,DEPT GYNECOL,KARLSKOGA,SWEDEN
[4] MED PRACTICE,HERNING,DENMARK
[5] MED PRACT,FARUM,DENMARK
[6] OSTRA SJUKHUSET,DEPT INTERNAL MED,S-41685 GOTHENBURG,SWEDEN
[7] SENTRALSYKEHUSET,DEPT GYNECOL & OBSTET,KRISTIANSTAD,NORWAY
[8] CARLANDERSKA SJUKHEMMET,GOTHENBURG,SWEDEN
[9] UNIV UPPSALA HOSP,DEPT OBSTET & GYNECOL,S-75014 UPPSALA,SWEDEN
[10] ORGANON SCI DEV GRP,OSS,NETHERLANDS
来源：
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 1982年
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：39 / 42
页数：4
相关论文
共 50 条
  • [41] EFFECTS OF 3 LOW-DOSE ORAL-CONTRACEPTIVE COMBINATIONS ON SEX-HORMONE BINDING GLOBULIN, CORTICOSTEROID BINDING GLOBULIN AND ANTITHROMBIN-III ACTIVITY IN HEALTHY WOMEN - 2 MONOPHASIC DESOGESTREL COMBINATIONS (CONTAINING 0.020 OR 0.030-MG ETHINYLESTRADIOL) AND ONE TRIPHASIC LEVONORGESTREL COMBINATION
    KLOOSTERBOER, HJ
    VANWAYJEN, RGA
    VANDENENDE, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 41 - 44
  • [42] Sexual behavior of women using an oral contraceptive containing 30 μg ethinylestradiol and 3 mg drospirenone
    Caruso, S
    Agnello, C
    Intelisano, G
    Farina, M
    Di Maria, L
    Sparacino, L
    Cianci, A
    [J]. HUMAN REPRODUCTION, 2005, : 847 - 851
  • [43] Phase III clinical trial with a new oral contraceptive containing 150 mu g desogestrel and 20 mu g ethinylestradiol
    Lammers, Paul
    op ten Berg, Monique
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1991, 70 (06) : 497 - 500
  • [44] Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg
    Hadji, Peyman
    Biskup, Jutta
    Boekhoff, Jelena
    Ziller, May
    Bonn, Michael
    Rovati, Lucio
    [J]. CONTRACEPTION, 2012, 86 (04) : 359 - 365
  • [45] PRE-SYSTEMIC METABOLISM OF THE ORAL-CONTRACEPTIVE STEROID DESOGESTREL
    BACK, DJ
    MADDEN, S
    MARTIN, CA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) : P675 - P676
  • [46] CLINICAL AND METABOLIC FEATURES OF DESOGESTREL - A NEW ORAL-CONTRACEPTIVE PREPARATION
    ARCHER, DF
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (05) : 1550 - 1555
  • [47] EFFECTS OF ORAL-CONTRACEPTIVE COMBINATIONS CONTAINING LEVONORGESTREL OR DESOGESTREL ON SERUM-PROTEINS AND ANDROGEN BINDING
    BERGINK, EW
    HOLMA, P
    PYORALA, T
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 (07): : 663 - 668
  • [48] SERUM-LIPIDS AND PROTEINS DURING TREATMENT WITH A NEW ORAL-CONTRACEPTIVE COMBINATION CONTAINING DESOGESTREL
    PENTTILA, IM
    BERGINK, EW
    HOLMA, P
    HULKKO, S
    MAKKONEN, M
    PYORALA, T
    CASTREN, O
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1983, 16 (04): : 275 - 281
  • [49] CONTINUOUS MICRODOSE (0.3 MG) QUINGESTANOL ACETATE AS AN ORAL-CONTRACEPTIVE AGENT
    JUBHARI, S
    LANE, ME
    SOBRERO, AJ
    [J]. CONTRACEPTION, 1974, 9 (03) : 213 - 219
  • [50] OVULATION INHIBITION WITH A COMBINED ORAL-CONTRACEPTIVE CONTAINING 1 MG MICRONIZED 17-BETA-ESTRADIOL
    WENZL, R
    BENNINK, HC
    VANBEEK, A
    SPONA, J
    HUBER, J
    [J]. FERTILITY AND STERILITY, 1993, 60 (04) : 616 - 619
12345